Vaccination: The Europeans were not "good enough" on the investment, according to Clément Beaune (Archives) -
Eric TSCHAEN-POOL / SIPA
French Secretary of State for European Affairs Clément Beaune said Wednesday that Europeans had not been "good enough" on the investment for the development of anti-Covid vaccines.
"There is one point on which we were not good enough, not strong enough, not fast enough, it is the investment in the development of the vaccine," he said on the French channel LCP.
A "decline in the pharmaceutical industry"
“There is a European dropout that is not new, which is a dropout of several years, several decades, it is our decline in the pharmaceutical industry, he added.
We have undoubtedly, it must be said (…) under-invested in investment and research capacities.
"
"We do not have, like the United States, a European agency (with) significant financial resources in terms of medical research and which would have been able to massively fund the laboratories in the last phase of research to accelerate the development of the vaccine", he stressed.
Reviews of late delivery
The European Commission, which negotiated the pre-orders on behalf of the Twenty-Seven, has come under fire of criticism following significant delays in delivery of the first three vaccines authorized in the EU, due to site difficulties production in Europe.
Commission President Ursula von der Leyen agreed on Wednesday that the EU had been "too optimistic" on deliveries and that it should beef up mass production to better prepare the Twenty-Seven for the spread of the new variants.
Health
Vaccination: People over 65 can receive AstraZeneca vaccine, WHO assures
Society
Vaccination in Ile-de-France: Is the region lagging behind to administer the anti-Covid vaccine?
Covid 19
Europe
Anti-covid vaccine
Coronavirus
Vaccination
Society